The risk of cutaneous mucormycosis associated with COVID‐19: A perspective from Pakistan-Reference-Cited by-同舟云学术

The risk of cutaneous mucormycosis associated with COVID‐19: A perspective from Pakistan

Author:

Asri Sucharu¹,Akram Muhammad Rizwan²,Hasan Mohammad Mehedi³^ORCID,Asad Khan Fatima Muhammad⁴,Hashmi Nida⁵,Wajid Fareha⁶⁷,Ullah Irfan⁸^ORCID

Affiliation:

1. Faculty of Medicine and Health Sciences (FMHS) Shree Guru Gobind Singh Tricentenary Medical College Haryana India

2. Sheikh Zayed Medical College and Hospital Punjab Pakistan

3. Department of Biochemistry and Molecular Biology, Faculty of Life Science Mawlana Bhashani Science and Technology University Tangail Bangladesh

4. Dow University of Health Sciences Karachi Pakistan

5. Karachi Medical and Dental College Karachi Pakistan

6. Jinnah Sindh Medical University Karachi Pakistan

7. California Institute of Behavioral Neurosciences and Psychology Fairfield California USA

8. Kabir Medical College, Gandhara University Peshawar Pakistan

Publisher

Wiley

Subject

Health Policy

Link

Reference15 articles.

1. 2021 WHO Pakistan WHO coronavirus disease (COVID‐19) dashboard with vaccination data

4. Drug resistant White fungus: another catastrophic fungus emergence amidst COVID‐19 in India;Ghosh S;Pathogens Glob Health,2021

5. Cutaneous mucormycosis;Castrejón‐Pérez AD;An Bras Dermatol,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献